Few aspects of health care in the United States arouse more passion than the direct prices of prescription drugs. Americans pay more for the same drugs than patients in other countries, and we pay a higher share of GDP for prescription drugs. As the federal government moves forward with the reforms initiated in recent years, …
How the new Congress can improve drug pricing reform Read More »
NEW YORK, December 9, 2022 /PRNewswire/ — Pharmaceutical Industry Regenerative Medicine Market Size, Share and Trend Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027 Read the full report: https://www.reportlinker.com/p06371494/?utm_source=PRN SummaryPharmacy regenerative medicine market size has been valued at US$29.4 billion in …
In a large study, the experimental drug lecanemab was able to slow Alzheimer’s disease, but not stop it. Some researchers believe that the drug will become the first to help many patients; others have questions. Cemile Bingol/Getty Images hide caption toggle caption Cemile Bingol/Getty Images In a large study, the experimental drug lecanemab was able …
Is lecanemab the drug against Alzheimer’s disease that will finally make a difference? Read More »
An all-new county program includes access to low-cost telemedicine services and increased discounts on prescription drugs. BOISE, Idaho – If you live in Ada County, Idaho, read carefully. There’s a brand new county program that includes access to low-cost telemedicine services and increased discounts on prescription drugs. Ada County recently switched to the Live Healthy …
Ada County Joins Prescription Drug Rebate Program Read More »
The coronavirus has been a sneaky enemy, with new variants and sub-variants rapidly evolving to evade vaccines and treatments. Researchers at Boston’s Dana-Farber Cancer Institute are working on an experimental drug that takes one of the virus’s most dangerous traits – its talent for mutation – and turns it against itself. When the coronavirus binds …
Experimental decoy drug tricks coronavirus, then destroys it Read More »
Cigna’s pharmacy benefits manager, Express Scripts, will offer “multiple” biosimilar versions of Abbvie … [+] the expensive rheumatoid arthritis drug Humira in the “same position as the brand” on PBMs as a formulary in 2023. AbbVie’s signature drug, Humira, is shown in this illustration Friday, July 18, 2014, in Houston. (AP Photo/David J. Phillip) Copyright …
Starting next month, a $35 cap on insulin prices will go into effect for millions of Medicare beneficiaries. The price cut is one of the first of several policy moves Americans will see in the months and years to come under the Cut Inflation Act signed into law in August. The bill also requires drug …
The experimental drug lecanemab showed a 27% slowing of the progression of cognitive decline in patients with early-stage Alzheimer’s disease, according to a study published this week in the New England Journal of Medicine. “These results show that lecanemab shows promise for people with early-stage Alzheimer’s disease, with a significant slowing of decline and a …
Experimental Alzheimer’s drug may slow disease progression, but there are risks: experts Read More »
An as yet unapproved drug shows promise for reducing cognitive decline in patients with Alzheimer’s disease. Whether it might work to prevent disease progression is the question in a new clinical trial of lecanemab, a monoclonal antibody developed by Japanese pharmaceutical company Eisai and Biogen of Massachusetts. Michigan’s only site, at the University of Michigan …
Drug study to examine Alzheimer’s disease prevention, research Michigan participants Read More »
As Japanese drugmaker Eisai this week presented data confirming it had developed the first drug to slow cognitive decline in Alzheimer’s patients, audiences at a conference in San Francisco erupted in applause. Among those present was Lars Lannfelt, a little-known Swedish scientist who invented the breakthrough drug, known as lecanemab, and will make a fortune …
The Swedish scientist behind the Alzheimer’s drug has big ambitions Read More »
